Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery

Conclusions: Our study identified several independent prognostic factors that might help determine the appropriate counseling patients following surgical treatment. D2 surgery alone was inadequate to achieve long-term survival. As the only correctable independent prognostic factor, postoperative adjuvant chemotherapy should be recommended for eligible patients with stage III gastric cancer.

Source: Journal of Cancer - June 20, 2018 Category: Cancer & Oncology Authors: Shin-Chun Chang, Keng-Hao Liu, Chia-Yen Hung, Chun-Yi Tsai, Jun-Te Hsu, Ta-Sen Yeh, Jen-Shi Chen, Yung-Chia Kuo, Yu-Shin Hung, Wen-Chi Chou Tags: Research Paper Source Type: research